Malignant hypertension in patients with idiopathic IgA nephropathy

Kidney and Blood Pressure Research

Volumn 28, Issue 4, 2005, Pages 251-258

  Chen, Yu ^a   Tang, Zheng ^a   Yang, Guang ^a   Shen, Shuqiong ^a   Yu, Yusheng ^a   Zeng, Caihong ^a   Chen, Huiping ^a   Liu, Zhi Hong ^a   Li, Lei Shi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Glomerulonephritis; IgA nephropathy; Malignant hypertension; Renal outcomes

Indexed keywords

CREATININE;

ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENDARTERITIS; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MALIGNANT HYPERTENSION; MESANGIUM CELL; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN METABOLISM; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL; UNIVARIATE ANALYSIS; URINARY EXCRETION; VASCULAR LESION;

ADOLESCENT; ADULT; BIOPSY; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION, MALIGNANT; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 30044451974     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090058     Document Type: Article

References (18)

1. Glla JH: IgA nephropathy. Kidney Int 1995;47:377-387.
2. Hass M: Histologic subclassification of IgA nephropathy: a clinicopathlogic study of 244 cases. Am J Kidney Dis 1997;29:829-842.
3. Cheng X, Zhao M, Li X: Clinical features and prognostic factors in chronic glomerulonephritis with malignant hypertension. Chin J Nephrol 2004;20:79-82.
4. Joint National Committee for the Detection, Evaluation and Treatment of High Blood Pressure: The 1984 report. Arch Intern Med 1984;114:1045-1057.
5. Kitiyakara C, Guzman NJ: Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 1998;9:133-142.
6. Xie Y, Nishi S, Ueno M: The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int 2003;63:1861-1867.
7. Joseph V, Paul EM: The diagnosis and management of hypertensive crises. Chest 2000;118:214-227.
8. Isles CG: Hypertensive emergencies; in Swales JD (ed): Textbook of Hypertension. Scientific Publications. Oxford, Blackwell, 1994, vol 35, pp 1233-1240.
9. Stamler J, Stamler R, Riedlenger WF: Hypertension screening of million Americans. Community Hypertension Evaluation Clinic (CHEC) Program 1973 through 1975. JAMA 1976;235:2299-2309.
10. Beutler JJ, Koomans HA: Malignant hypertension: still a challenge. Nephrol Dial Transplant 1997;12:2019-2023.
11. James SH, Meyers AM, Milne FJ: Partial recovery of renal function in black patients with apparent end-stage renal failure due to primary malignant hypertension. Nephron 1995;71:29-34.
12. Lawton WJ: The short-term course of renal function in malignant hypertensives with renal insufficiency. Clin Nephrol 1982;17:277-285.
13. Klag MJ, Wheton PK, Randall BL: End-stage renal disease in African-American and white man: 16-years MRFIT findings. J Am Med Assoc 1997;277:1293-1299.
14. Subias R, Botey A, Darnell A: Malignant or accelerated hypertension in IgA nephropathy. Clin Nephrol 1987;27:1-7.
15. Perez-Fontan M, Miguel JL, Picazo ML, et al: Idiopathic IgA nephropathy presenting as malignant hypertension. Am J Nephrol 1986;6:482-486.
16. Lens XM, Montoliu J, Aubias R, Botey A, Darnell A, Revert L: Malignant essential hypertension: comparison with malignant hypertension in IgA nephropathy (abstract). Kidney Int 1985;28:25015.
17. Kawazoe N, Eto T, Abe I: Long-term prognosis of malignant hypertension: difference between underlying diseases such as essential hypertension and chronic glomerulonephritis. Clin Nephrol 1988;29:53-57.
18. Scarpelli PT, Gallo M, Cesaris FD: Continuing follow-up of malignant hypertension. J Nephrol 2002;15:431-437.